A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma

The current standard treatments of glioma include surgical resection, supplemented with radiotherapy and chemotherapy, but the prognosis is poor. PARP-1 (Poly ADP-ribose polymerase 1) is a hot spot for cancer-targeted therapy and was reported to be significantly elevated in glioma. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Wang, Zhenhua, Hou, Yuanyuan, Xi, Jianxin, He, Zhenqiang, Lu, Han, Du, Zhishan, Zhong, Sheng, Yang, Qunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450093/
https://www.ncbi.nlm.nih.gov/pubmed/36092717
http://dx.doi.org/10.3389/fcell.2022.916415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450093/
https://www.ncbi.nlm.nih.gov/pubmed/36092717
http://dx.doi.org/10.3389/fcell.2022.916415

Ejemplares similares